Table 4

Correlations between MMPs, TIMPs, MPO and measures of left ventricular dysfunction and remodelling

	LVEF% at 5 days (n=58)	LVEF% at 4 months (n=46)	dEDVI (n=46)	dESVI (n=46)
MMP-2
0 h	−0.332*	−0.296*	−0.091	−0.056
12 h	−0.412**	−0.403**	−0.123	−0.151
24 h	−0.260	−0.245	−0.033	−0.001
48 h	−0.202	−0.203	0.031	0.152
MMP-8
0 h	−0.113	−0.183	0.022	−0.195
12 h	−0.119	−0.207	−0.322*	−0.273
24 h	−0.055	−0.024	−0.020	−0.080
48 h	−0.100	−0.193	−0.125	−0.282
MMP-9
0 h	−0.247	−0.260	−0.039	−0.204
12 h	−0.264	−0.258	−0.288	−0.207
24 h	−0.110	−0.045	0.033	−0.027
48 h	−0.130	−0.230	−0.105	−0.228
TIMP-1
0 h	−0.257	−0.228	−0.174	−0.076
12 h	−0.249	−0.168	−0.231	−0.096
24 h	−0.368*	−0.345*	−0.261	−0.261
48 h	−0.356*	−0.270	−0.305*	−0.185
TIMP-2
0 h	−0.334*	−0.236	0.001	0.092
12 h	−0.359*	−0.328*	0.044	0.088
24 h	−0.176	−0.211	−0.019	0.015
48 h	−0.164	−0.267	−0.043	0.092
MPO
0 h	−0.214	−0.167	−0.155	−0.204
12 h	−0.092	−0.117	−0.198	−0.134
24 h	−0.112	−0.014	−0.109	−0.033
48 h	−0.212	−0.313*	−0.199	−0.347*

*p<0.05, **p<0.01.
Values are given as ρ values from the Spearman test.
dEDVI, change in end-diastolic volume index from 5 days to 4 months; dESVI, change in end-systolic volume index from 5 days to 4 months; LVEF, left ventricular ejection fraction; MMP, matrix metalloproteinase; MPO, myeloperoxidase; n, number of patients; TIMP, tissue inhibitor of metalloproteinase.